Pearson BTEC Level 3 National In Applied Human Biology
PearsonBTEC Level 3 National inApplied HumanBiologyUnit 1: Principles of AppliedHuman BiologySampleAssessmentMaterials (SAMs)For use with Certificate and Extended Certificate inApplied Human BiologyFirst teaching from September 2018Issue 1
Edexcel, BTEC and LCCI qualificationsEdexcel, BTEC and LCCI qualifications are awarded by Pearson, the UK’s largestawarding body offering academic and vocational qualifications that are globallyrecognised and benchmarked.For further information, please visit our qualifications website atqualifications.pearson.com. Alternatively, you can get in touch with us using the detailson our contact us page at qualifications.pearson.com/contactusAbout PearsonPearson is the world's leading learning company, with 35,000 employees in more than70 countries working to help people of all ages to make measurable progress in theirlives through learning. We put the learner at the centre of everything we do, becausewherever learning flourishes, so do people. Find out more about how we can help youand your learners at qualifications.pearson.comReferences to third-party material made in this specification are made ingood faith. Pearson does not endorse, approve or accept responsibility for thecontent of materials, which may be subject to change, or any opinionsexpressed therein. (Material may include textbooks, journals, magazines andother publications and websites.)ISBN 978 1 446 95857 5All the material in this publication is copyright Pearson Education Limited 2018
Contents PageUnit 1 Question Paper1Unit 1 Mark Scheme21
Please check the examination details below before entering your candidate informationCandidate surnamePearson BTECLevel 3NationalsCentre NumberOther namesLearner Registration NumberSample assessment material for first teachingXxxxxxx 2018Time: 1 hour 30 minutesPaper Reference XXXXX/XXApplied Human BiologyUnit 1: Principles of Applied Human BiologyYou must have:A ruler and a calculatorTotal MarksInstructionsblack ink or ball-point pen. UseFillinboxes at the top of this page with your name, centrethenumber and learner registration number.all questions. Answerthe questions in the spaces provided Answer– there may be more space than you need.Informationtotal mark for this paper is 80. Themarks for each question are shown in brackets The– use this as a guide as to how much time to spend on each question.Adviceeach question carefully before you start to answer it. Readto answer every question. Try Check your answers if you have time at the end.Turn overS62846A 2018 Pearson Education Ltd.1/1/1*S62846A0119*Pearson BTEC Level 3 Nationals in Applied Human Biology – Unit 1 – Final Sample Assessment MaterialsIssue 1 – September 2018 Pearson Education Limited 20181
Answer ALL questions. Write your answers in the spaces provided.Some questions must be answered with a cross in a box . If you change your mind about ananswer, put a line through the box and then mark your new answer with a cross .1 Figure 1 shows part of the plasma membrane of a cell.ACBDFigure 1(a) Which molecule labelled in Figure 1 is a channel protein?(1)ABCD22*S62846A0219*Pearson BTEC Level 3 Nationals in Applied Human Biology – Unit 1 – Final Sample Assessment MaterialsIssue 1 – September 2018 Pearson Education Limited 2018
(b) Proteins contain peptide bonds between amino acids.Complete the structure of a peptide bond.(1)(c) Collagen is a structural protein.Explain two ways in which collagen is suited to its role.(4)1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .(Total for Question 1 6 marks)*S62846A0319*Pearson BTEC Level 3 Nationals in Applied Human Biology – Unit 1 – Final Sample Assessment MaterialsIssue 1 – September 2018 Pearson Education Limited 201833Turn over
2 Transcription is the first step of gene expression in cells.(a) Here is a short sequence of DNAAGCCTAWhich of the following would be the correct mRNA sequence when transcribed?(1)A AGCCTAB UCGGAUC GCAAUGD TCGGAT(b) A sequence of DNA contains 35% guanine.Show that the proportion of alanine is 15%(2)% .44*S62846A0419*Pearson BTEC Level 3 Nationals in Applied Human Biology – Unit 1 – Final Sample Assessment MaterialsIssue 1 – September 2018 Pearson Education Limited 2018
(c) Describe how a gene is transcribed from DNA in the nucleus.(4). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .(Total for Question 2 7 marks)*S62846A0519*Pearson BTEC Level 3 Nationals in Applied Human Biology – Unit 1 – Final Sample Assessment MaterialsIssue 1 – September 2018 Pearson Education Limited 201855Turn over
3 (a) Cystic fibrosis (CF) is an inherited condition. Approximately 1 in every 25 people inthe United Kingdom carries the allele for CF.A woman can be tested during pregnancy to see if the fetus has CF.Describe the chorionic villus sampling test carried out on a pregnant woman.(3). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .(b) People with cystic fibrosis need a diet that has a higher energy content thanpeople who do not have cystic fibrosis.Explain why people with cystic fibrosis need to have a diet with a higher energycontent.(6). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .(Total for Question 3 9 marks)66*S62846A0619*Pearson BTEC Level 3 Nationals in Applied Human Biology – Unit 1 – Final Sample Assessment MaterialsIssue 1 – September 2018 Pearson Education Limited 2018
4 The immune system responds to pathogens by producing antibodies.The human body can also respond to the presence of allergens.(a) Give the name of the type of white blood cell that allows rapid production ofantibodies in a secondary immune response.(1). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .(b) Explain how antibodies are involved in the destruction of a specific pathogen.(3). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .*S62846A0719*Pearson BTEC Level 3 Nationals in Applied Human Biology – Unit 1 – Final Sample Assessment MaterialsIssue 1 – September 2018 Pearson Education Limited 201877Turn over
(c) Prescriptions of adrenaline autoinjectors are recommended for patients withsevere allergies that may result in anaphylaxis.One symptom of anaphylaxis is the swelling of tissues.(i) Explain how swelling is triggered in an anaphylactic reaction.(2). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .(ii) Explain two ways in which adrenaline can help to reduce other immediatesymptoms of anaphylaxis.(4)1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .(Total for Question 4 10 marks)88*S62846A0819*Pearson BTEC Level 3 Nationals in Applied Human Biology – Unit 1 – Final Sample Assessment MaterialsIssue 1 – September 2018 Pearson Education Limited 2018
5 The monitoring of heart and lung structure and function is important for diagnosinghealth issues.Figure 2 shows a cross-section through the human heart.(a) Which order of the chambers would a red blood cell go through on its way frommuscle tissue to the brain?(1)PSQRFigure 2A P, Q, R, SB Q, P , S, RC R, S, Q, PD S, R, P, Q*S62846A0919*Pearson BTEC Level 3 Nationals in Applied Human Biology – Unit 1 – Final Sample Assessment MaterialsIssue 1 – September 2018 Pearson Education Limited 201899Turn over
Figure 3 shows how the pressure changes in the ventricles of a normal human heartover time.12111098Pressure / kPa7Key:6left ventricleright ventricle54321000.10.20.3Time / sFigure 3(b) (i) Describe the changes in the left ventricle wall that lead to an increase inpressure in the left ventricle.(2). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1010*S62846A01019*Pearson BTEC Level 3 Nationals in Applied Human Biology – Unit 1 – Final Sample Assessment MaterialsIssue 1 – September 2018 Pearson Education Limited 2018
(b) (ii) Explain why the pressures shown for each ventricle are different.(3). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Jun 18, 2008 · Pearson BTEC Level 3 National in Applied Human Biology Unit 1: Principles of Applied Human Biology Sample Assessment Materials (SAMs) For use with Certificate and Extended Certificate in Applied Human Biology First teaching from Sept
Pearson BTEC Level 4 HNC The Pearson BTEC Level 4 HNC in Business is a qualification with a minimum of 120 credits of which 60 are mandatory core. The Pearson BTEC Level 4 HNC programme must contain a minimum of 65 credits at level 4. Pearson BTEC Level 5 HND The Pearson BTEC Lev
Technology Pearson BTEC Level 3 National Foundation Diploma in Information Technology First teaching 2016 Pearson BTEC Level 3 National Diploma (2017) in Information Technology Pearson BTEC Level 3 National Extended Diploma (2017) in Information Technology First teaching 2017 . Edexcel, BTEC and LCCI qualifications Edexcel, BTEC and LCCI qualifications are awarded by Pearson, the UK’s .
Qualification sizes for BTEC Firsts in the Business sector 6 3 Pearson BTEC Level 1/Level 2 First Diploma in Business 9 Rationale for the Pearson BTEC Level 1/Level 2 First Diploma in Business 9 4 Qualification structure 14 Qualification structure of the Pearson BTEC Level 1/Level 2 First Diplom
BTEC Level 4 HNC The Pearson BTEC Level 4 HNC in Business (QCF) is a qualification with a minimum of 120 credits of which 60 are mandatory core. The BTEC Level 4 HNC programme must contain a minimum of 65 credits at level 4. BTEC Level 5 HND The Pearson BTEC Level 5 HND in Business (QCF) is a qualification with a
Pearson BTEC Level 4 HNC Diploma in Automotive Engineering Pearson BTEC Level 5 HND Diploma in Automotive Engineering The BTEC HNCs (Higher National Certificates) are now at level 4 and are a minimum of 120 credits in size. They have been nested within the structures of the BTEC HNDs (Higher National Diplomas). BTEC HNDs are level 5 qualifications.
Pearson BTEC Level 3 National Extended Certificate in Computing (360 GLH) 601/7341/5 . Pearson BTEC Level 3 National Foundation Diploma in Computing (510 G LH) 601/7343/9 . Pearson BTEC Level 3 National Diploma in Computing (720 GL H) 603/0445/5 . Pearson BTEC Level 3 National Extended Diploma in C omputing (1080 GLH) 601/7342/7.
at the same level and adding value to them. In the business sector these qualifications are: Pearson BTEC Level 3 National Certificate in Business (180 GLH) 601/7155/8 . Pearson BTEC Level 3 National Extended Certificate in Business (360 GLH) 601/7159/5 . Pearson BTEC Level 3 National Foundation Diploma in Business (510 GLH) 601/7161/3
4.2.1 Pearson BTEC Level 4 Higher National Certificate in Engineering 29 4.2.2 Pearson BTEC Level 5 Higher National Diploma in Engineering 38 4.2.3 Meeting local needs (MLN) 57 4.2.4 Pearson BTEC Higher National Commissioned Development 58 4.3 Pearson-Set Units 59 4.4 The unit descriptor 60 4.5 Professional Body collaboration 63
